14-Jul-2021
Globalization and Health
This paper examines civil society and health actors’ views of the conditions that successfully contributed to the removal of these measures in RCEP, with a focus on intellectual property and access to medicines.
18-May-2021
The Ecologist
The shadowy parallel court system of major trade agreements makes it difficult for countries to ban broad-spectrum insecticides.
11-May-2021
The Independent
‘It would be grossly hypocritical for the government to allow unsustainable meat to be served in schools and hospitals,’ say critics
25-Feb-2021
The Conversation
The COVID-19 pandemic, and the race to make vaccines and other useful technologies more accessible to people around the world, has once again highlighted the tension between intellectual property rights and the promotion of public health.
3-Nov-2020
Open Democracy
Whether a UK deal with an ’America First’ president, or Biden’s more traditional global trade stance, battles ahead are likely if Britain is to protect its NHS and avoid higher drug prices.
20-Oct-2020
Friends of the Earth International
Our call to suspend all ISDS cases during and beyond the COVID-19 crisis.
11-Sep-2020
National Magazine
Tensions are likely to surface between the public-policy directions of governments managing a challenging economic climate and foreign investors’ private interests.
4-Sep-2020
International Law Office
With state measures in response to COVID-19 being compounded by an already difficult economic environment for investors, they may have little choice but to challenge those measures.
28-Aug-2020
Corrs Chambers Westgarth
In response to the COVID-19 pandemic, governments globally are engaging in a difficult balancing act of protecting public health, mitigating economic damage and avoiding interference with private rights.
